Mechanism by which moxibustion pretreatment attenuates oxidative stress injury in a rat model of cerebral ischemia-reperfusion

doi:10.12307/2024.308

Abstract

Abstract: BACKGROUND: Pretreatment with moxibustion is a preventive treatment in traditional Chinese medicine. Pretreatment with moxibustion at the onset of prodromal symptoms can significantly reduce the symptoms and delay the onset of many diseases, but the exact mechanism remains to be studied.
OBJECTIVE: To investigate the mechanism of SIRT1/FoxO3 pathway in moxibustion pretreatment to ameliorate oxidative stress injury in cerebral ischemia-reperfusion model rats.
METHODS: Forty-eight Sprague-Dawley rats were randomly divided into sham-operated group, model group, moxibustion pretreatment group, and moxibustion pretreatment+EX527 (SIRT1 inhibitor) group, with 12 rats in each group. The moxibustion pretreatment group was given moxibustion with seed-sized moxa cone at Baihui, Dazhui, and Zusanli before modeling, three moxa-cones per acupoint, once a day for 7 days. In the model group, moxibustion pretreatment group and moxibustion pretreatment+EX527 group, the rat model of middle cerebral artery occlusion was made by suturing of the middle cerebral artery 30 minutes after the last moxibustion. After 2 hours of cerebral ischemia, the middle artery suture was removed and the rats were reperfused for 12 hours. In the sham-operated group, only the common carotid artery, internal carotid artery, and external carotid artery were dissected without suturing the middle cerebral artery. In the moxibustion pretreatment+EX527 group, EX527 (15 mg/kg) was given intraperitoneally 30 minutes before each moxibustion. After 12 hours of reperfusion, the rats were scored for neurological deficits, and the cerebral infarct volume was calculated by 2,3,5-triphenyltetrazolium chloride staining method. The levels of oxidative stress factors in the infarcted tissues were detected by the kit method, and western-blot method was used to detect the expression levels of SIRT1, FoxO3, p-FoxO3 and brain-derived neurotrophic factor in the ischemic area of the cerebral cortex.
RESULTS AND CONCLUSION: After 12 hours of reperfusion, the neurobehavioral score in the model group was significantly higher than that in the sham-operated group (P < 0.01), while the score in the moxibustion pretreatment group was significantly lower than that in the model group (P < 0.01) and moxibustion pretreatment+EX527 group (P < 0.05). There were no obvious infarct foci in the brain tissue of the sham-operated rats, but obvious ischemic foci were observed in the right side of the brain tissue of the rats in the model group (P < 0.01). The right infarct volume in the moxibustion pretreatment group was significantly reduced compared with the model group (P < 0.01), while the right infarct volume in the moxibustion pretreatment+EX527 group was significantly enlarged compared with the moxibustion pretreatment group. After 12 hours of reperfusion, the level of malondialdehyde was significantly elevated (P < 0.01) and the expression of superoxide dismutase was significantly decreased (P < 0.01) in the model group compared with the sham-operated group. The levels of malondialdehyde was significantly decreased (P < 0.01, P < 0.05) and the expression of superoxide dismutase was significantly increased (P < 0.01, P < 0.05) in the moxibustion pretreatment group compared with the model group and the moxibustion pretreatment+EX527 group. Western blot results showed that the expression levels of SIRT1, FoxO3, p-FoxO3, and brain-derived neurotrophic factor proteins were significantly higher in the model group compared with the sham-operated group (P < 0.01); compared with the model group, the expression levels of SIRT1, FoxO3, and brain-derived neurotrophic factor were significantly higher in the moxibustion pretreatment group (P < 0.01), and p-FoxO3 expression was significantly lower (P < 0.01); compared with the moxibustion pretreatment+EX527 group, the expression levels of SIRT1, FoxO3, and brain-derived neurotrophic factor were elevated in the moxibustion pretreatment group (P < 0.05), and no statistically significant difference was found in the p-FoxO3 expression (P > 0.05). To conclude, moxibustion pretreatment can significantly improve neurological function in rats after cerebral ischemia-reperfusion, and the mechanism may be related to the activation of SIRT1/FoxO3 pathway to reduce oxidative stress injury in the rat model of cerebral ischemia-reperfusion.

Key words: moxibustion pretreatment, ischemia-reperfusion, oxidative stress, SIRT1, FoxO3

CLC Number:

Jiang Jie, Liu Juan, Yu Yanyan, Yang Yue, Wang Qianhui. Mechanism by which moxibustion pretreatment attenuates oxidative stress injury in a rat model of cerebral ischemia-reperfusion[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(16): 2488-2493.

Figures/Tables 4

References

[1] TIAN H, ZHAO Y, DU C, et al. Expression of mir-210, mir-137, and mir-153 in patients with acute cerebral infarction. BioMed Research International. Biomed Res Int. 2021;2021:4464945.
[2] HE J, XUAN X, JIANG M, et al. Long non-coding rna snhg1 relieves microglia activation by downregulating mir-329-3p expression in anin vitromodel of cerebral infarction. Experimental and Therapeutic Medicine. Exp Ther Med. 2021;22(4):1148.
[3] ZHANG X, ZHOU G. mir-199a-5p inhibition protects cognitive function of ischemic stroke rats by akt signaling pathway. American Journal of Translational Research. Am J Transl Res. 2020;12(10):6549-6558.
[4] WU X, ZHANG X, LI D, et al. Plasma level of mir-99b may serve as potential diagnostic and short-term prognostic markers in patients with acute cerebral infarction. J Clin Lab Anal. 2020;34:e23093.
[5] WEI YX, ZHAO X, ZHANG BC. Synergistic effect of moxibustion and rehabilitation training in functional recovery of post-stroke spastic hemiplegia. Complement Ther Med. 2016,26:55-60.
[6] 林子涵,阮传亮,周文强,等.辰时腹部艾灸治疗中风后下肢痉挛及对肌肉结构参数的影响[J].中国针灸,2020,40(10):1042-1046.
[7] 陈澄澄,宁松毅,杨静,等.艾灸预处理在癌症患者化疗后骨髓抑制中的应用[J].中华现代护理杂志,2021,27(1):38-43.
[8] 金洵,吕兴,韦艳会,等.不同时间艾灸预处理对卵巢储备功能减退大鼠卵巢功能的影响[J].针刺研究,2019,44(11):817-821.
[9] 蒋洁,赵百孝,陈立彬,等.灸法预处理脑缺血再灌注模型大鼠自噬及NLRP3炎症小体的表达[J].中国组织工程研究,2022,26(23): 3615-3619.
[10] LONGA EZ, WEINSTEIN PR, CARLSON S, et al. Reversible middlece- rebral artery occlusion without craniectomy in rats. Stroke.1989;20(1): 84-91.
[11] 李忠仁. 实验针灸学[M].北京:中国中医药出版社,2003:316.
[12] VIRANI SS, ALONSO A, APARICIO HJ, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743.
[13] FESKE SK. Ischemic Stroke. Am J Med. 2021;134(12):1457-1464.
[14] MENDELSON SJ, PRABHAKARAN S. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA. 2021;325(11):1088-1098.
[15] HOLLIST M, MORGAN L, CABATBAT R,et al. Acute Stroke Management: Overview and Recent Updates. Aging Dis. 2021;12(4):1000-1009.
[16] JAYARAJ RL, AZIMULLAH S, BEIRAM R, et a. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142.
[17] ORELLANA-URZÚA S, ROJAS I, LÍBANO L, et al. Pathophysiology of Ischemic Stroke: Role of Oxidative Stress. Curr Pharm Des. 2020; 26(34):4246-4260.
[18] UZDENSKY AB. Apoptosis regulation in the penumbra after ischemic stroke: expression of pro- and antiapoptotic proteins. Apoptosis. 2019; 24(9-10):687-702.
[19] AMANTEA D,BAGETTA G.Excitatory and inhibitory amino acid neurotransmitters in stroke: from neurotoxicity to ischemic tolerance. Curr Opin Pharmacol. 2017;35:111-119.
[20] 李晓泓.针灸“治未病”与“针灸良性预应激假说”[J]. 北京中医药大学学报,2003,26(3):82-85.
[21] 周哲屹. 瑶医神火灸对缺血再灌注大鼠神经保护作用和机制研究[D].广州:广州中医药大学,2019.
[22] XIONG XY, WANG J, QIAN ZM, et al.Iron and intracerebral hemorrhage: from mechanism to translation. Transl Stroke Res. 2014;5(4):429-441.
[23] MA YH, DENG WJ, LUO ZY, et al. Inhibition of microRNA-29b suppresses oxidative stress and reduces apoptosis in ischemic stroke. Neural Regen Res. 2022;17(2):433-439.
[24] WAN J, REN H, WANG J.Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage. Stroke Vasc Neurol. 2019;4(2):93-95.
[25] NIIZUMA K, YOSHIOKA H, CHEN H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta. 2010;1802(1):92-99.
[26] ZHANG XS, LU Y, LI W, et al. Cerebroprotection by dioscin after experimental subarachnoid haemorrhage via inhibiting NLRP3 inflammasome through SIRT1-dependent pathway. Br J Pharmacol. 2021;178(18):3648-3666.
[27] MAO H, WANG L, XIONG Y, et al. Fucoxanthin Attenuates Oxidative Damage by Activating the Sirt1/Nrf2/HO-1 Signaling Pathway to Protect the Kidney from Ischemia-Reperfusion Injury. Oxid Med Cell Longev. 2022;2022:7444430.
[28] YANG Y, DUAN W, LI Y, et al. New role of silent information regulator 1 in cerebral ischemia. Neurobiol Aging. 2013;34(12):2879-2888.
[29] ACCILI D, ARDEN KC.FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;117(4):421-426.
[30] MANGIA A, SAPONARO C, VAGHEGGINI A, et al. Should tumor infiltrating lymphocytes, androgen receptor, and FOXA1 expression predict the clinical outcome in triple negative breast cancer patients?. Cancers. 2019;11(9):1393.
[31] BRUNET A, SWEENEY LB, STURGILL JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303(5666):2011-2015.
[32] GILLEY J, COFFER PJ, HAM J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol. 2003;162(4):613-622.
[33] WU Y, HUANG Y, CAI J, et al. LncRNA SNHG12 improves cerebral ischemic-reperfusion injury by activating SIRT1/FOXO3a pathway through I nhibition of autophagy and oxidative stress. Curr Neurovasc Res. 2020;17(4):394-401.
[34] DUAN J, CUI J, ZHENG H, et al. Aralia taibaiensis protects against I/R-induced brain cell injury through the Akt/SIRT1/FOXO3a pathway. Oxid Med Cell Longev. 2019;2019:7609765.